Polycythaemia Vera

Diagnosis and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Haematology

Clinical Guidelines

A guideline for the diagnosis and management of polycythaemia vera
National
CKS: Polycythaemia/erythrocytosis
National
NICE guidance on ruxolitinib for polycythaemia vera
National
NICE guideline [NG180]
National
NICE guideline [TA921]: Ruxolitinib for treating polycythaemia vera
National
Overview | Ruxolitinib for treating polycythaemia vera | Guidance
National
Pan-London Haemato-Oncology Clinical Guidelines
National
A guideline for the diagnosis and management of polycythaemia vera (British Society for Haematology Guideline, 2019)
Local
A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis (British Society for Haematology Guideline, 2019)
Local
Diagnosis and management of polycythaemia vera (British Society for Haematology Guideline, 2018)
Local
ESMO Clinical Practice Guideline: Philadelphia Chromosome-negative Chronic Myeloproliferative Neoplasms
Local
Management of specific situations in polycythaemia vera and secondary erythrocytosis (British Society for Haematology Guideline, 2018)
Local
NCCN Clinical Practice Guidelines in Oncology: Myeloproliferative Neoplasms
Local
NICE technology appraisal [TA921]: Ruxolitinib for treating polycythaemia vera
Local
Onkopedia Guideline: Polycythaemia Vera (PV)
Local
Pan-London Haemato-Oncology Clinical Guidelines: Myeloproliferative Neoplasms
Local